EDDC Academic Research Organisation or EARO, is a Fee-for-Service initiative by the Experimental Drug Development Centre (EDDC). Founded in 2020, EARO was conceived to provide greater access to EDDC’s rich scientific expertise and state of the art technology platforms to the academic and industry researchers in the biomedical ecosystem who aspire to embark on a journey of translating their research into drug candidates.
EARO comprises primarily of 5 core drug discovery platforms headed by scientists with decades of experience. The EARO Platforms include High Throughput Screening (HTS), Fragment Based Screening (FBS), Protein Crystallography (XRAY), High Throughput Phenomics (HTP) and Computational Phenomics Platform (CPP).
A researcher may engage EARO for:
Feel free to drop us your enquiry on EARO initiative, our platforms and how we can support you in your drug discovery journey at email@example.com
- Contract research: Provision of specific or end-to-end drug discovery capabilities to researchers in an interactive and collaborative manner
- Equipment access: A range of equipment accessible on pay-per-use basis. Researchers can either book time via booking system or request for assistance by expert to perform the experiments on their behalf
- Expert consultation: Engage with subject matter experts who can provide in-depth scientific knowledge to help researchers navigate the challenges faced during early stages of drug discovery